These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 38162671)

  • 1. One-month assessment of Th-cell axis related inflammatory cytokines, IL-17 and IL-22 and their role in alcohol-associated liver disease.
    Sagaram M; Frimodig J; Jayanty D; Hu H; Royer AJ; Bruner R; Kong M; Schwandt ML; Vatsalya V
    Front Immunol; 2023; 14():1202267. PubMed ID: 38162671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theragnostic Efficacy of K18 Response in Alcohol Use Disorder with Clinically Significant Fibrosis Using Gut-Liver Axis.
    Sagaram M; Parthasarathy R; Condon SL; Closson CF; Kong M; Schwandt ML; Jophlin LL; Feng W; Barve AJ; Vatsalya V
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Hypomagnesemia in Alcoholic Hepatitis Patients and Its Association with Liver Injury and Severity Markers.
    Winrich EJ; Tiwari H; Gala KS; Royer AJ; Parajuli D; Vatsalya V
    J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance.
    Fujimoto M; Uemura M; Nakatani Y; Tsujita S; Hoppo K; Tamagawa T; Kitano H; Kikukawa M; Ann T; Ishii Y; Kojima H; Sakurai S; Tanaka R; Namisaki T; Noguchi R; Higashino T; Kikuchi E; Nishimura K; Takaya A; Fukui H
    Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):48S-54S. PubMed ID: 10803780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary acrolein metabolite levels in severe acute alcoholic hepatitis patients.
    Vatsalya V; Kong M; Gobejishvili L; Chen WY; Srivastava S; Barve S; McClain C; Joshi-Barve S
    Am J Physiol Gastrointest Liver Physiol; 2019 Jan; 316(1):G115-G122. PubMed ID: 30234998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highest frequencies of interleukin-22-producing T helper cells in alcoholic hepatitis patients with a favourable short-term course.
    Støy S; Sandahl TD; Dige AK; Agnholt J; Rasmussen TK; Grønbæk H; Deleuran B; Vilstrup H
    PLoS One; 2013; 8(1):e55101. PubMed ID: 23372820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute Kidney Injury (AKI) at Admission Predicts Mortality in Patients With Severe Alcoholic Hepatitis (SAH).
    Khatua CR; Panigrahi MK; Choudhury AK; Nath G; Khandelwal R; Anirvan P; Singh SP
    J Clin Exp Hepatol; 2023; 13(2):225-232. PubMed ID: 36950492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gut-immune-liver axis in patients with alcohol use disorder and clinically low serum zinc levels.
    Thakurdesai A; Jha SK; Erinkitola I; Said A; Joshi T; Schwandt ML; Parajuli D; Singal AK; Kong M; Cave MC; Vatsalya V
    Alcohol Clin Exp Res (Hoboken); 2024 Aug; ():. PubMed ID: 39095327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol abstinence ameliorates the dysregulated immune profiles in patients with alcoholic hepatitis: A prospective observational study.
    Li W; Amet T; Xing Y; Yang D; Liangpunsakul S; Puri P; Kamath PS; Sanyal AJ; Shah VH; Katz BP; Radaeva S; Crabb DW; Chalasani N; Yu Q
    Hepatology; 2017 Aug; 66(2):575-590. PubMed ID: 28466561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Hypomagnesemia and Liver Injury, Role of Gut-Barrier Dysfunction and Inflammation: Efficacy of Abstinence, and 2-Week Medical Management in Alcohol Use Disorder Patients.
    Winrich EJ; Gala KS; Rajhans A; Rios-Perez CD; Royer AJ; Zamani Z; Parthasarathy R; Marsano-Obando LS; Barve AJ; Schwandt ML; Vatsalya V
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel paradigms for the gut-brain axis during alcohol withdrawal, withdrawal-associated depression, and craving in patients with alcohol use disorder.
    Vatsalya V; Verster JC; Sagaram M; Royer AJ; Hu H; Parthasarathy R; Schwandt ML; Kong M; Ramchandani VA; Feng W; Agrawal R; Zhang X; McClain CJ
    Front Psychiatry; 2023; 14():1203362. PubMed ID: 37840804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Illustration of Gut-Thyroid Axis in Alcohol Use Disorder: Interplay of Gut Dysfunction, Pro-Inflammatory Responses, and Thyroid Function.
    Sagaram M; Royer AJ; Hu H; Rajhans A; Parthasarathy R; Krishnasamy SS; Mokshagundam SP; Kong M; Schwandt ML; Parajuli D; Cave MC; Vatsalya V
    Cells; 2022 Oct; 11(19):. PubMed ID: 36231061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Early-Stage Alcoholic Liver Disease with Hyperhomocysteinemia and Gut Dysfunction and Associated Immune Response in Alcohol Use Disorder Patients.
    Vatsalya V; Gala KS; Hassan AZ; Frimodig J; Kong M; Sinha N; Schwandt ML
    Biomedicines; 2020 Dec; 9(1):. PubMed ID: 33374263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACG Clinical Guideline: Alcohol-Associated Liver Disease.
    Jophlin LL; Singal AK; Bataller R; Wong RJ; Sauer BG; Terrault NA; Shah VH
    Am J Gastroenterol; 2024 Jan; 119(1):30-54. PubMed ID: 38174913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol Abstinence Does Not Fully Reverse Abnormalities of Mucosal-Associated Invariant T Cells in the Blood of Patients With Alcoholic Hepatitis.
    Li W; Lin EL; Liangpunsakul S; Lan J; Chalasani S; Rane S; Puri P; Kamath PS; Sanyal AJ; Shah VH; Radaeva S; Crabb DW; Chalasani N; Yu Q
    Clin Transl Gastroenterol; 2019 Jun; 10(6):e00052. PubMed ID: 31211759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern recognition receptor CD14 gene polymorphisms in alcohol use disorder patients and its Influence on liver disease susceptibility.
    Roy N; Nadda N; Kumar H; Prasad C; Kumar Jha J; Pandey HC; Vanamail P; Saraya A; Balhara YPS; Shalimar ; Nayak B
    Front Immunol; 2022; 13():975027. PubMed ID: 36238273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics identifies complement protein signatures in patients with alcohol-associated hepatitis.
    Taiwo M; Huang E; Pathak V; Bellar A; Welch N; Dasarathy J; Streem D; McClain CJ; Mitchell MC; Barton BA; Szabo G; Dasarathy S; ; Schaefer EA; Luther J; Day LZ; Ouyang X; Suyavaran A; Mehal WZ; Jacobs JM; Goodman RP; Rotroff DM; Nagy LE
    JCI Insight; 2024 Apr; 9(9):. PubMed ID: 38573776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Status of Alcoholic Liver Disease in Japan and Therapeutic Strategy.
    Horie Y; Ebinuma H; Kikuchi M; Lamao Takanori
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2016 Aug; 51(2):71-90. PubMed ID: 30462383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with early-stage alcohol-associated liver disease are at increased risk of hospital readmission and death.
    Aryan M; Qian S; Chen Z; Louissaint J; Qian X; Rosenblatt R; Verna E; Brown R; Wong R; Clark V; Zhang W
    Eur J Gastroenterol Hepatol; 2024 Mar; 36(3):318-325. PubMed ID: 38179871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating concentrations of interleukin-18, interleukin-18 binding protein, and gamma interferon in patients with alcoholic hepatitis.
    Spahr L; Garcia I; Bresson-Hadni S; Rubbia-Brandt L; Guler R; Olleros M; Chvatchko Y; Hadengue A
    Liver Int; 2004 Dec; 24(6):582-7. PubMed ID: 15566508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.